Table 3
New morbidity and unfavorable functional outcome for overall survivors who required VA-ECLS stratified by PaO2 levels into hyperoxia and non-hyperoxia groups based on functional status scale change from admission to discharge.
| ECLS Group | Overall cohort of survivors (n = 127) | Non-hyperoxia group | Hyperoxia group | p-value |
|---|---|---|---|---|
| PaO2 ≤ 233 mmHg (n = 96) | PaO2 > 233 mmHg (n = 31) | |||
| New morbidity (Change in FSS score ≥3 points) | 30 (23.6%) | 21 (21.9%) | 9 (29.0%) | 0.415 |
| Unfavorable outcome (Change in FSS score ≥5 points) | 10 (7.9%) | 8 (8.3%) | 2 (6.5%) | 0.735 |
FSS Subscale scores range from 1 to 5. Total scores are the sum of subscale scores, ranging from 6 to 30.
FSS: Functional Status Scale; ECLS: Extracorporeal Life Support.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.